Galanin receptor 2-neuropeptide Y Y1 receptor interactions in the dentate gyrus are related with antidepressant-like effects

Brain Structure and Function

Volumn 221, Issue 8, 2016, Pages 4129-4139

  Narváez, Manuel ^a   Borroto Escuela, Dasiel O ^b   Millón, Carmelo ^a   Gago, Belén ^a   Flores Burgess, Antonio ^a   Santín, Luis ^c   Fuxe, Kjell ^b   Narváez, José Angel ^a   Díaz Cabiale, Zaida ^a  

^a UNIVERSIDAD DE MÁLAGA   (Spain)

^b KAROLINSKA INSTITUTE   (Sweden)

^c UNIVERSITY OF MÁLAGA   (Spain)

Author keywords

Depression; Galanin; Interaction; Neuropeptide Y

Indexed keywords

GALANIN RECEPTOR 2; NEUROPEPTIDE Y; NEUROPEPTIDE Y Y1 RECEPTOR; PROTEIN C FOS; UNCLASSIFIED DRUG; GALANIN; MESSENGER RNA; NEUROPEPTIDE Y RECEPTOR; NEUROPEPTIDE Y-Y1 RECEPTOR;

ADULT; ANIMAL EXPERIMENT; ANTIDEPRESSANT ACTIVITY; ARTICLE; ASSAY; AUTORADIOGRAPHY; BRAIN REGION; CELL ACTIVATION; CELL SPECIFICITY; CONTROLLED STUDY; DENTATE GYRUS; DEPRESSION; FORCED SWIM TEST; HIPPOCAMPUS; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; IN SITU HYBRIDIZATION; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; PROXIMITY LIGATION ASSAY; QUANTITATIVE STUDY; RAT; AGONISTS; ANIMAL; METABOLISM; NERVE CELL; SPRAGUE DAWLEY RAT;

ANIMALS; DENTATE GYRUS; DEPRESSION; GALANIN; MALE; NEURONS; RATS; RATS, SPRAGUE-DAWLEY; RECEPTOR, GALANIN, TYPE 2; RECEPTORS, NEUROPEPTIDE Y; RNA, MESSENGER;

EID: 84949744995     PISSN: 18632653     EISSN: 18632661     Source Type: Journal    
DOI: 10.1007/s00429-015-1153-1     Document Type: Article

References (50)

1. Amaral DG, Scharfman HE, Lavenex P (2007) The dentate gyrus: fundamental neuroanatomical organization (dentate gyrus for dummies). Prog Brain Res 163:3–22. doi:10.1016/S0079-6123(07)63001-5
2. Andrews-Zwilling Y, Gillespie AK, Kravitz AV, Nelson AB, Devidze N, Lo I, Yoon SY, Bien-Ly N, Ring K, Zwilling D, Potter GB, Rubenstein JL, Kreitzer AC, Huang Y (2012) Hilar GABAergic interneuron activity controls spatial learning and memory retrieval. PLoS One 7(7):e40555. doi:10.1371/journal.pone.0040555
3. Barr AM, Kinney JW, Hill MN, Lu X, Biros S, Rebek J Jr, Bartfai T (2006) A novel, systemically active, selective galanin receptor type-3 ligand exhibits antidepressant-like activity in preclinical tests. Neurosci Lett 405(1–2):111–115. doi:10.1016/j.neulet.2006.06.033
4. Bettio LE, Freitas AE, Neis VB, Dos Santos DB, Ribeiro CM, Rosa PB, Farina M, Rodrigues AL (2014) Guanosine prevents behavioral alterations in the forced swimming test and hippocampal oxidative damage induced by acute restraint stress. Pharmacol Biochem Behav. doi:10.1016/j.pbb.2014.10.002
5. Bjornebekk A, Mathe AA, Brene S (2010) The antidepressant effects of running and escitalopram are associated with levels of hippocampal NPY and Y1 receptor but not cell proliferation in a rat model of depression. Hippocampus 20(7):820–828. doi:10.1002/hipo.20683
6. Blackstad TW, Fuxe K, Hokfelt T (1967) Noradrenaline nerve terminals in the hippocampal region of the rat and the guinea pig. Zeitschrift fur Zellforschung und mikroskopische Anatomie 78(4):463–473
7. Borroto-Escuela DO, Romero-Fernandez W, Garriga P, Ciruela F, Narvaez M, Tarakanov AO, Palkovits M, Agnati LF, Fuxe K (2013) G protein-coupled receptor heterodimerization in the brain. Methods Enzymol 521:281–294. doi:10.1016/B978-0-12-391862-8.00015-6
8. Borroto-Escuela DO, Narvaez M, Di Palma M, Calvo F, Rodriguez D, Millon C, Carlsson J, Agnati LF, Garriga P, Diaz-Cabiale Z, Fuxe K (2014) Preferential activation by galanin 1–15 fragment of the GalR1 protomer of a GalR1-GalR2 heteroreceptor complex. Biochem Biophys Res Commun 452(3):347–353. doi:10.1016/j.bbrc.2014.08.061
9. Burgess N, Maguire EA, O’Keefe J (2002) The human hippocampus and spatial and episodic memory. Neuron 35(4):625–641
10. Caberlotto L, Jimenez P, Overstreet DH, Hurd YL, Mathe AA, Fuxe K (1999) Alterations in neuropeptide Y levels and Y1 binding sites in the Flinders Sensitive Line rats, a genetic animal model of depression. Neurosci Lett 265(3):191–194
11. Campbell S, Macqueen G (2004) The role of the hippocampus in the pathophysiology of major depression. Journal of psychiatry & neuroscience: JPN 29(6):417–426
12. Catena-Dell’Osso M, Fagiolini A, Marazziti D, Baroni S, Bellantuono C (2013) Non-monoaminergic targets for the development of antidepressants: focus on neuropeptides. Mini Rev Med Chem 13(1):2–10
13. Clark PJ, Bhattacharya TK, Miller DS, Rhodes JS (2011) Induction of c-Fos, Zif268, and Arc from acute bouts of voluntary wheel running in new and pre-existing adult mouse hippocampal granule neurons. Neuroscience 184:16–27. doi:10.1016/j.neuroscience.2011.03.072
14. Depczynski B, Nichol K, Fathi Z, Iismaa T, Shine J, Cunningham A (1998) Distribution and characterization of the cell types expressing GALR2 mRNA in brain and pituitary gland. Ann N Y Acad Sci 863:120–128
15. Diaz-Cabiale Z, Parrado C, Narvaez M, Puigcerver A, Millon C, Santin L, Fuxe K, Narvaez JA (2011) Galanin receptor/Neuropeptide Y receptor interactions in the dorsal raphe nucleus of the rat. Neuropharmacology 61(1–2):80–86. doi:10.1016/j.neuropharm.2011.03.002
16. Duffy AM, Schaner MJ, Chin J, Scharfman HE (2013) Expression of c-fos in hilar mossy cells of the dentate gyrus in vivo. Hippocampus 23(8):649–655. doi:10.1002/hipo.22138
17. Dumont Y, Fournier A, St-Pierre S, Quirion R (1996) Autoradiographic distribution of [125I]Leu31, Pro34]PYY and [125I]PYY3-36 binding sites in the rat brain evaluated with two newly developed Y1 and Y2 receptor radioligands. Synapse 22(2):139–158. doi:10.1002/(SICI)1098-2396(199602)22:2<139:AID-SYN7>3.0.CO;2-E
18. Fuxe K, Borroto-Escuela DO, Romero-Fernandez W, Tarakanov AO, Calvo F, Garriga P, Tena M, Narvaez M, Millon C, Parrado C, Ciruela F, Agnati LF, Narvaez JA, Diaz-Cabiale Z (2012) On the existence and function of galanin receptor heteromers in the central nervous system. Front Endocrinol (Lausanne) 3:127. doi:10.3389/fendo.2012.00127
19. Hagihara H, Takao K, Walton NM, Matsumoto M, Miyakawa T (2013) Immature dentate gyrus: an endophenotype of neuropsychiatric disorders. Neural Plast 2013:318596. doi:10.1155/2013/318596
20. Hansson AC, Fuxe K (2008) Time-course of immediate early gene expression in hippocampal subregions of adrenalectomized rats after acute corticosterone challenge. Brain Res 1215:1–10. doi:10.1016/j.brainres.2008.03.080
21. Hiroaki-Sato VA, Sales AJ, Biojone C, Joca SR (2014) Hippocampal nNOS inhibition induces an antidepressant-like effect: involvement of 5HT1A receptors. Behav Pharmacol 25(3):187–196. doi:10.1097/FBP.0000000000000035
22. Holmes A, Heilig M, Rupniak NM, Steckler T, Griebel G (2003) Neuropeptide systems as novel therapeutic targets for depression and anxiety disorders. Trends Pharmacol Sci 24(11):580–588. doi:10.1016/j.tips.2003.09.011
23. Jacobowitz DM, Kresse A, Skofitsch G (2004) Galanin in the brain: chemoarchitectonics and brain cartography—a historical review. Peptides 25(3):433–464. doi:10.1016/j.peptides.2004.02.015
24. Jimenez-Vasquez PA, Diaz-Cabiale Z, Caberlotto L, Bellido I, Overstreet D, Fuxe K, Mathe AA (2007) Electroconvulsive stimuli selectively affect behavior and neuropeptide Y (NPY) and NPY Y(1) receptor gene expressions in hippocampus and hypothalamus of Flinders Sensitive Line rat model of depression. European neuropsychopharmacology: the journal of the European College of Neuropsychopharmacology 17(4):298–308. doi:10.1016/j.euroneuro.2006.06.011
25. Jinde S, Zsiros V, Jiang Z, Nakao K, Pickel J, Kohno K, Belforte JE, Nakazawa K (2012) Hilar mossy cell degeneration causes transient dentate granule cell hyperexcitability and impaired pattern separation. Neuron 76(6):1189–1200. doi:10.1016/j.neuron.2012.10.036
26. Kohler C, Eriksson L, Davies S, Chan-Palay V (1986) Neuropeptide Y innervation of the hippocampal region in the rat and monkey brain. J Comp Neurol 244(3):384–400. doi:10.1002/cne.902440310
27. Kormos V, Gaszner B (2013) Role of neuropeptides in anxiety, stress, and depression: from animals to humans. Neuropeptides 47(6):401–419. doi:10.1016/j.npep.2013.10.014
28. Kotagale NR, Paliwal NP, Aglawe MM, Umekar MJ, Taksande BG (2013) Possible involvement of neuropeptide Y Y1 receptors in antidepressant like effect of agmatine in rats. Peptides 47:7–11. doi:10.1016/j.peptides.2013.04.018
29. Kuteeva E, Wardi T, Hokfelt T, Ogren SO (2007) Galanin enhances and a galanin antagonist attenuates depression-like behaviour in the rat. Euro Neuropsychopharm J Euro Coll Neuropsychopharm 17(1):64–69. doi:10.1016/j.euroneuro.2006.03.003
30. Kuteeva E, Wardi T, Lundstrom L, Sollenberg U, Langel U, Hokfelt T, Ogren SO (2008) Differential role of galanin receptors in the regulation of depression-like behavior and monoamine/stress-related genes at the cell body level. Neuropsychopharm Off Publ Am Coll Neuropsychopharmacol 33(11):2573–2585. doi:10.1038/sj.npp.1301660
31. Ledri M, Nikitidou L, Erdelyi F, Szabo G, Kirik D, Deisseroth K, Kokaia M (2012) Altered profile of basket cell afferent synapses in hyper-excitable dentate gyrus revealed by optogenetic and two-pathway stimulations. Euro J Neurosci 36(1):1971–1983. doi:10.1111/j.1460-9568.2012.08080.x
32. Li B, Suemaru K, Kitamura Y, Gomita Y, Araki H, Cui R (2013) Imipramine-induced c-Fos expression in the medial prefrontal cortex is decreased in the ACTH-treated rats. J Biochem Mol Toxicol 27(11):486–491. doi:10.1002/jbt.21510
33. Madsen TM, Greisen MH, Nielsen SM, Bolwig TG, Mikkelsen JD (2000) Electroconvulsive stimuli enhance both neuropeptide Y receptor Y1 and Y2 messenger RNA expression and levels of binding in the rat hippocampus. Neuroscience 98(1):33–39
34. Masana M, Castane A, Santana N, Bortolozzi A, Artigas F (2012) Noradrenergic antidepressants increase cortical dopamine: potential use in augmentation strategies. Neuropharmacology 63(4):675–684. doi:10.1016/j.neuropharm.2012.05.020
35. Mathe AA, Jimenez PA, Theodorsson E, Stenfors C (1998) Neuropeptide Y, neurokinin A and neurotensin in brain regions of Fawn Hooded “depressed”, Wistar, and Sprague Dawley rats. Effects of electroconvulsive stimuli. Prog Neuropsychopharmacol Biol Psychiatry 22(3):529–546
36. McEwen BS, Magarinos AM (1997) Stress effects on morphology and function of the hippocampus. Ann N Y Acad Sci 821:271–284
37. Millon C, Flores-Burgess A, Narvaez M, Borroto-Escuela DO, Santin L, Parrado C, Narvaez JA, Fuxe K, Diaz-Cabiale Z (2014) A Role For Galanin N-Terminal Fragment (1–15) In Anxiety- And Depression-Related Behaviours In Rats. Int J Neuropsychopharmacol/Off Sci J Coll Int Neuropsychopharmacol. doi:10.1093/ijnp/pyu064
38. Narvaez M, Millon C, Borroto-Escuela D, Flores-Burgess A, Santin L, Parrado C, Gago B, Puigcerver A, Fuxe K, Narvaez JA, Diaz-Cabiale Z (2015) Galanin receptor 2-neuropeptide Y Y1 receptor interactions in the amygdala lead to increased anxiolytic actions. Brain Struct Funct 220(4):2289–2301. doi:10.1007/s00429-014-0788-7
39. O’Donnell D, Ahmad S, Wahlestedt C, Walker P (1999) Expression of the novel galanin receptor subtype GALR2 in the adult rat CNS: distinct distribution from GALR1. J Comp Neurol 409(3):469–481
40. Paredes MF, Greenwood J, Baraban SC (2003) Neuropeptide Y modulates a G protein-coupled inwardly rectifying potassium current in the mouse hippocampus. Neurosci Lett 340(1):9–12
41. Parrado C, Diaz-Cabiale Z, Garcia-Coronel M, Agnati LF, Covenas R, Fuxe K, Narvaez JA (2007) Region specific galanin receptor/neuropeptide Y Y1 receptor interactions in the tel- and diencephalon of the rat. Relevance for food consumption. Neuropharmacology 52(2):684–692. doi:10.1016/j.neuropharm.2006.09.010
42. Petit-Demouliere B, Chenu F, Bourin M (2005) Forced swimming test in mice: a review of antidepressant activity. Psychopharmacology 177(3):245–255. doi:10.1007/s00213-004-2048-7
43. Porsolt RD, Le Pichon M, Jalfre M (1977) Depression: a new animal model sensitive to antidepressant treatments. Nature 266(5604):730–732
44. Redrobe JP, Dumont Y, Fournier A, Quirion R (2002) The neuropeptide Y (NPY) Y1 receptor subtype mediates NPY-induced antidepressant-like activity in the mouse forced swimming test. Neuropsychopharmacol Off Publ Am Coll Neuropsychopharmacol 26(5):615–624. doi:10.1016/S0893-133X(01)00403-1
45. Saar I, Lahe J, Langel K, Runesson J, Webling K, Jarv J, Rytkonen J, Narvanen A, Bartfai T, Kurrikoff K, Langel U (2013) Novel systemically active galanin receptor 2 ligands in depression-like behavior. J Neurochem 127(1):114–123. doi:10.1111/jnc.12274
46. Scharfman HE, Sollas AL, Goodman JH (2002) Spontaneous recurrent seizures after pilocarpine-induced status epilepticus activate calbindin-immunoreactive hilar cells of the rat dentate gyrus. Neuroscience 111(1):71–81
47. Sperk G, Hamilton T, Colmers WF (2007) Neuropeptide Y in the dentate gyrus. Prog Brain Res 163:285–297. doi:10.1016/S0079-6123(07)63017-9
48. Stogner KA, Holmes PV (2000) Neuropeptide-Y exerts antidepressant-like effects in the forced swim test in rats. Eur J Pharmacol 387(2):R9–R10
49. Wrenn CC, Holmes A (2006) The role of galanin in modulating stress-related neural pathways. Drug News Perspect 19(8):461–467
50. Yoshitake S, Kuteeva E, Hokfelt T, Mennicken F, Theodorsson E, Yamaguchi M, Kehr J, Yoshitake T (2014) Correlation between the effects of local and intracerebroventricular infusions of galanin on 5-HT release studied by microdialysis, and distribution of galanin and galanin receptors in prefrontal cortex, ventral hippocampus, amygdala, hypothalamus, and striatum of awake rats. Synapse 68(5):179–193. doi:10.1002/syn.21730